|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
1985-3-21
|
|
pubmed:abstractText |
Thirty-nine patients with acute enteric fever received the fixed-dose oral combination of pivmecillinam/pivampicillin. Thirty-seven (95%) subjects responded satisfactorily. No relapses or persistent faecal excretion of salmonellae were seen in the 29 patients followed up for 2 to 19 weeks. The treatment was well tolerated, no side-effects being recorded. In vitro studies revealed a synergistic interaction between mecillinam and ampicillin against isolates of Salmonella paratyphi A.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0300-8126
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
12
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
381-3
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:6569851-Adolescent,
pubmed-meshheading:6569851-Adult,
pubmed-meshheading:6569851-Aged,
pubmed-meshheading:6569851-Amdinocillin,
pubmed-meshheading:6569851-Amdinocillin Pivoxil,
pubmed-meshheading:6569851-Ampicillin,
pubmed-meshheading:6569851-Drug Combinations,
pubmed-meshheading:6569851-Female,
pubmed-meshheading:6569851-Humans,
pubmed-meshheading:6569851-Male,
pubmed-meshheading:6569851-Middle Aged,
pubmed-meshheading:6569851-Penicillin Resistance,
pubmed-meshheading:6569851-Pivampicillin,
pubmed-meshheading:6569851-Salmonella,
pubmed-meshheading:6569851-Typhoid Fever
|
|
pubmed:articleTitle |
The combination of pivmecillinam and pivampicillin in the treatment of enteric fever.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study
|
